David Klein, Ph.D.

CDER, FDA
Silver Spring, Maryland, United States

Presentation(s):

• FDA Montelukast Working Group Studies: Identification of Off-Target Neurological Receptors and Potential Molecular Mechanisms of Drug-Related Neuropsychiatric Adverse Effects (P208)

  Monday, November 18, 2024
  5:00 PM - 6:30 PM CT